NCT05263895
- Conditions
- Bioavailability, COVID-19, Coronaviridae Infections, +10 more
- Locations
-
- Pfizer Clinical Research Unit - New Haven New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.
NCT05263895
NCT04613375
NCT06576167
NCT05107271
NCT05142306
NCT04661839
NCT04287959
NCT06582277
NCT06970366
NCT05022472